Laassili C, Ben El Hend F, Benzidane R, Oumeslakht L, Aziz A, El Fatimy R
Front Immunol. 2023; 14:1188497.
PMID: 37564652
PMC: 10410254.
DOI: 10.3389/fimmu.2023.1188497.
Coenon L, Villalba M
Front Immunol. 2022; 13:913215.
PMID: 35720368
PMC: 9203678.
DOI: 10.3389/fimmu.2022.913215.
van Houtum E, Bull C, Cornelissen L, Adema G
Front Immunol. 2021; 12:790317.
PMID: 34966391
PMC: 8710542.
DOI: 10.3389/fimmu.2021.790317.
Zanna M, Yasmin A, Omar A, Arshad S, Mariatulqabtiah A, Nur-Fazila S
Int J Mol Sci. 2021; 22(15).
PMID: 34360810
PMC: 8348663.
DOI: 10.3390/ijms22158044.
Brian 4th B, Freedman T
Endocrinology. 2021; 162(10).
PMID: 34320188
PMC: 8389176.
DOI: 10.1210/endocr/bqab152.
The Inhibitory Receptor CLEC12A Regulates PI3K-Akt Signaling to Inhibit Neutrophil Activation and Cytokine Release.
Pare G, Vitry J, Merchant M, Vaillancourt M, Murru A, Shen Y
Front Immunol. 2021; 12:650808.
PMID: 34234773
PMC: 8256872.
DOI: 10.3389/fimmu.2021.650808.
Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections.
Keeler S, Fox J
Viruses. 2021; 13(6).
PMID: 34072720
PMC: 8226613.
DOI: 10.3390/v13061037.
TLR7 Is Critical for Anti-Viral Humoral Immunity to EV71 Infection in the Spinal Cord.
Lin Y, Lu M, Chuang C, Kuo Y, Lin H, Li F
Front Immunol. 2021; 11:614743.
PMID: 33679702
PMC: 7935532.
DOI: 10.3389/fimmu.2020.614743.
Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1.
Xu L, Wang S, Li J, Li J, Li B
Oncoimmunology. 2021; 9(1):1740477.
PMID: 33457088
PMC: 7790510.
DOI: 10.1080/2162402X.2020.1740477.
The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma.
Joseph C, Alsaleem M, Toss M, Kariri Y, Althobiti M, Alsaeed S
Cancers (Basel). 2021; 13(1).
PMID: 33396670
PMC: 7795350.
DOI: 10.3390/cancers13010080.
Polymorphisms in Fc Gamma Receptors and Susceptibility to Malaria in an Endemic Population.
Amiah M, Ouattara A, Okou D, NGuetta S, Yavo W
Front Immunol. 2020; 11:561142.
PMID: 33281811
PMC: 7689034.
DOI: 10.3389/fimmu.2020.561142.
Co-inhibitory Receptor Signaling in T-Cell-Mediated Autoimmune Glomerulonephritis.
Nagai K
Front Med (Lausanne). 2020; 7:584382.
PMID: 33251233
PMC: 7672203.
DOI: 10.3389/fmed.2020.584382.
Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants.
Thulin N, Brewer R, Sherwood R, Bournazos S, Edwards K, Ramadoss N
Cell Rep. 2020; 31(6):107642.
PMID: 32402275
PMC: 7344335.
DOI: 10.1016/j.celrep.2020.107642.
Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease.
Fitzpatrick E, Wang J, Strome S
Front Immunol. 2020; 11:496.
PMID: 32269572
PMC: 7109252.
DOI: 10.3389/fimmu.2020.00496.
The Diverse Functions of the Ubiquitous Fcγ Receptors and Their Unique Constituent, FcRγ Subunit.
Hamdan T, Lang P, Lang K
Pathogens. 2020; 9(2).
PMID: 32093173
PMC: 7168688.
DOI: 10.3390/pathogens9020140.
Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.
Ben Mkaddem S, Benhamou M, Monteiro R
Front Immunol. 2019; 10:811.
PMID: 31057544
PMC: 6481281.
DOI: 10.3389/fimmu.2019.00811.
Multiple Variables at the Leukocyte Cell Surface Impact Fc γ Receptor-Dependent Mechanisms.
Patel K, Roberts J, Barb A
Front Immunol. 2019; 10:223.
PMID: 30837990
PMC: 6382684.
DOI: 10.3389/fimmu.2019.00223.
Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
Gomez G
Front Immunol. 2019; 10:175.
PMID: 30792720
PMC: 6374298.
DOI: 10.3389/fimmu.2019.00175.
Lineage-Specific Functionality of an Interferon Regulatory Factor 5 Lupus Risk Haplotype: Lack of B Cell Intrinsic Effects.
Calise J, Marquez Renteria S, Gregersen P, Diamond B
Front Immunol. 2018; 9:996.
PMID: 29867973
PMC: 5949527.
DOI: 10.3389/fimmu.2018.00996.
Role of Bruton's tyrosine kinase in B cells and malignancies.
Singh S, Dammeijer F, Hendriks R
Mol Cancer. 2018; 17(1):57.
PMID: 29455639
PMC: 5817726.
DOI: 10.1186/s12943-018-0779-z.
